Compounds > dibutyryl cyclic-3',5'-cytidine monophosphate
Page last updated: 2024-09-03

dibutyryl cyclic-3',5'-cytidine monophosphate and 20-alpha-dihydroprogesterone

dibutyryl cyclic-3',5'-cytidine monophosphate has been researched along with 20-alpha-dihydroprogesterone in 1 studies

Compound Research Comparison

Studies
(dibutyryl cyclic-3',5'-cytidine monophosphate)		Trials
(dibutyryl cyclic-3',5'-cytidine monophosphate)		Recent Studies (post-2010)
(dibutyryl cyclic-3',5'-cytidine monophosphate)		Studies
(20-alpha-dihydroprogesterone)		Trials
(20-alpha-dihydroprogesterone)		Recent Studies (post-2010) (20-alpha-dihydroprogesterone)
72018534426

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abidi, P; Azhar, S; Cortez, Y; Han, J; Leers-Sucheta, S; Shen, WJ; Zaidi, SM; Zhang, H1

Other Studies

1 other study(ies) available for dibutyryl cyclic-3',5'-cytidine monophosphate and 20-alpha-dihydroprogesterone

ArticleYear
Oxidative stress-induced inhibition of adrenal steroidogenesis requires participation of p38 mitogen-activated protein kinase signaling pathway.
    The Journal of endocrinology, 2008, Volume: 198, Issue:1

    Topics: 20-alpha-Dihydroprogesterone; Adrenal Glands; Adrenocorticotropic Hormone; Animals; Cell Line, Tumor; Cyclic CMP; MAP Kinase Kinase 3; MAP Kinase Kinase 6; MAP Kinase Signaling System; Mice; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphoproteins; Phosphorylation; Superoxides

2008